Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

October 26, 2023 by Sally Floyd 3 min read

World CRISPR Day 2023: How Mission Bio Celebrates Genome Editing Innovation

Last week we celebrated World CRISPR Day, a day reserved to recognize the remarkable impact of CRISPR technology on research and medicine. In light of celebrating this ground-breaking genome editing technology, this year we’re thrilled to have recently unveiled the Tapestri Genome Editing Solution.

This new solution is already transforming the way genome engineers analyze CRISPR-based disease models, functional genomics screens, and gene-edited based cell and gene therapies. With the ability to provide high-throughput analysis at single-cell resolution, this innovative solution is a game-changer through its comprehensive, multi-omic approach.

The Tapestri Genome Editing Solution offers insights into a spectrum of critical parameters that bulk assays cannot easily ascertain:

  • On- and Off-Target Edits: Get a complete picture of both intended and unintended genetic modifications with precision.
  • Zygosity: Understand the allelic distribution of edits within a cell population.
  • Co-occurrence of Edits: Explore the complex interplay of multiple edits within a single cell.
  • High-throughput analysis without any computational labor: Sequencing analysis is automated, and reports are intuitive.

This means genome engineers can now delve into the intricacies of CRISPR outcomes, paving the way for breakthroughs in diverse life science applications, including the development of safer and more efficacious cell and gene therapies.

Dive Deeper with Our White Paper

To explore the full capabilities of the Tapestri Genome Editing Solution, be sure to check out our latest white paper. It offers an in-depth exploration of the pipeline’s capabilities, its impact on genomic analysis, and its potential to drive advancements in the field of genome editing.

Mission Bio Takes Genome Editing Analysis on the Road

The Mission Bio team is hitting the road over the next few weeks and will be attending a few upcoming conferences. This week, we headed to Brussels, Belgium for the the European Society of Gene and Cell Therapy (ESGCT) Annual Congress. We had a fantastic time connecting with industry and academic professionals, and enjoyed presenting several posters including:


The 30th European Society of Gene and Cell Therapy Annual Congress


The Mission Bio team ready to help!


For an update on our work with the National Institute of Standards and Technology Genome Editing Consortium (NIST), don’t miss Dr. Samantha Maragh’s poster, “NIST Genome Editing Consortium interlab study to evaluate the performance of DNA detection technologies in use for confirming genome editing.”

On October 30, the team will be at the CRISPR-Based Therapy Analytical Development Summit in Boston, Massachusetts. We’re eager to see and hear the leading advancements toward developing more precise, safer, and more effective CRISPR-based therapies.

Mission Bio researchers are also eager to present and participate in the NIST Genome Editing Consortium Public Workshop November 2 in Rockville, Maryland. The team is excited to present results from the initial Interlab Study, which consisted of 14 participants evaluating various genomic technologies in an effort to standardize and improve gene editing analysis.

We hope to see you out in the field soon. Until then, Happy World CRISPR Day 2023!

April 17, 2024
Publication Highlight: Clonal dominance defines metastatic dissemination in pancreatic cancer
March 21, 2024
Looking Forward: The Potential of Single-cell to Accelerate Clinical Research & Development
February 29, 2024
CRISPR-edited gene pools: Exploring variation in gene-edited cells
February 9, 2024
Synthego’s Eclipse CRISPR Engineering Platform & Mission Bio’s Tapestri Deliver Innovative Genome Editing Solutions: A Webinar Recap